Systematic review of clinician-directed nudges in healthcare contexts
BMJ Open
Authors
Briana S Last, Alison M Buttenheim, Carter E Timon, Nandita Mitra, Rinad S Beidas
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study
Annals of the American Thoracic SocietyMarch 20, 2024 -
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations
Nature Human BehaviourMarch 14, 2024 -
Health Care Use Among Patients Retroactively Insured via a Hospital-Based Insurance Linkage Program
Journal of General Internal MedicineMarch 14, 2024 -
The Next Decade of Healthcare
HealthcareFebruary 29, 2024 -
Changes in Health Care Workers' Economic Outcomes Following Medicaid Expansion
JAMAFebruary 27, 2024 -
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine
CephalalgiaFebruary 27, 2024 -
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools
Journal of AsthmaFebruary 9, 2024 -
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
Clinical Lymphoma Myeloma LeukemiaFebruary 8, 2024 -
A Social Network Analysis of Hemodialysis Clinics: Attitudes Towards Living Donor Kidney Transplant Among Influential Patients
Kidney360February 7, 2024 -
Differential Hospital Participation in Bundled Payments in Communities with Higher Shares of Marginalized Populations
Journal of General Internal MedicineFebruary 6, 2024 -
Officer-Involved Killings of Unarmed Black People and Racial Disparities in Sleep Health
JAMA Internal MedicineFebruary 5, 2024 -
Real-World Analysis of Adverse Event Rates After Initiation of Ibrutinib Among Medicare Beneficiaries With Chronic Lymphocytic Leukemia
Cancer MedicineFebruary 1, 2024